Coagulation studies in haemophilic patients taking oral contraceptives
Open Access
- 1 February 1971
- journal article
- clinical trial
- Published by BMJ in Journal of Clinical Pathology
- Vol. 24 (1) , 23-26
- https://doi.org/10.1136/jcp.24.1.23
Abstract
Coagulation studies were performed on haemophilic patients during a controlled trial of oral contraceptive therapy. Treatment with a combined oestrogen-progestogen preparation was associated with a significant rise in the factor VII-X complex. This change was not observed during treatment with progestogen alone. The highest levels of factor IX and fibrinogen and the lowest levels of factor X were observed during the first period of the trial but these effects were independent of the type of treatment. The results suggest that the effects of oral contraceptives on blood coagulation in haemophilic males are similar to those observed in normal females and that the changes are due to the oestrogenic component.Keywords
This publication has 16 references indexed in Scilit:
- Progesterone oral contraception and blood coagulation.BMJ, 1969
- Effects of Low-dose Oral Contraceptives on Blood CoagulationBMJ, 1968
- Increased factor IX levels in puerperium during administration of diethylstilboestrol.BMJ, 1968
- THROMBOEMBOLISM AND ŒSTROGEN THERAPYThe Lancet, 1967
- Risk of thromboembolic disease in women taking oral contraceptives. A preliminary communication to the Medical Research Council by a Subcommittee.BMJ, 1967
- ORAL CONTRACEPTIVES FOR HqMOPHILIAThe Lancet, 1967
- Clotting Factors during Oral Contraception: Further ReportBMJ, 1966
- Oral Contraceptive Hormones and Blood CoagulabilityBMJ, 1965
- Oral Contraception and Blood CoagulabilityBMJ, 1963
- The Specific Assay of Prower-Stuart Factor and Factor VIIActa Haematologica, 1961